Synergy scores were normalized using Min-Max Scaling to facilitate visual comparisons.
DrugCom Name |
DrugCom ID |
Component Drug |
Indication |
REF |
(-)-englerin A + CHS-828
|
DCGXXAE
|
(-)-englerin A
|
Ewing sarcoma (Cell Line: TC-71)
|
[2] |
ABT-263 + CHS-828
|
DCVE351
|
ABT-263
|
Ewing sarcoma (Cell Line: TC-71)
|
[3] |
CHS-828 + Carfilzomib
|
DCSTHF3
|
Carfilzomib
|
Diffuse intrinsic pontine glioma (Cell Line: DIPG25)
|
[2] |
CHS-828 + Panobinostat
|
DCXZIYB
|
Panobinostat
|
Diffuse intrinsic pontine glioma (Cell Line: DIPG25)
|
[2] |
CHS-828 + Eltanexor oral
|
DCMBERR
|
Eltanexor oral
|
Ewing sarcoma (Cell Line: TC-71)
|
[2] |
CHS-828 + Everolimus
|
DCCVZXX
|
Everolimus
|
Ewing sarcoma (Cell Line: TC-71)
|
[2] |
CHS-828 + Daporinad
|
DCS2EXP
|
Daporinad
|
Ewing sarcoma (Cell Line: TC-71)
|
[2] |
CHS-828 + AZD8330
|
DCHMCXD
|
AZD8330
|
Diffuse intrinsic pontine glioma (Cell Line: DIPG25)
|
[2] |
CHS-828 + Ruxolitinib
|
DCWWS4M
|
Ruxolitinib
|
Hodgkin lymphoma (Cell Line: L-1236)
|
[3] |
Daporinad + CHS-828
|
DC6GF3C
|
Daporinad
|
Ewing sarcoma (Cell Line: TC-71)
|
[2] |
Doxorubicin + CHS-828
|
DC4CWGL
|
Doxorubicin
|
Ewing sarcoma (Cell Line: TC-71)
|
[2] |
Evacetrapib + CHS-828
|
DCWVYOT
|
Evacetrapib
|
Diffuse intrinsic pontine glioma (Cell Line: DIPG25)
|
[2] |
Flucytosine + CHS-828
|
DC4JHV2
|
Flucytosine
|
Embryonal rhabdomyosarcoma (Cell Line: CTR)
|
[2] |
Flucytosine + CHS-828
|
DCC68AB
|
Flucytosine
|
Embryonal rhabdomyosarcoma (Cell Line: RD)
|
[2] |
JQ1 + CHS-828
|
DC8EPRF
|
JQ1
|
Ewing sarcoma (Cell Line: TC-71)
|
[2] |
MK-1775 + CHS-828
|
DCUMDKR
|
MK-1775
|
Ewing sarcoma (Cell Line: TC-71)
|
[2] |
OSI-906 + CHS-828
|
DCVLYUG
|
OSI-906
|
Ewing sarcoma (Cell Line: TC-71)
|
[3] |
PHA-739358 + CHS-828
|
DCID0R0
|
PHA-739358
|
Ewing sarcoma (Cell Line: TC-71)
|
[2] |
Romidepsin + CHS-828
|
DCIZHXI
|
Romidepsin
|
Ewing sarcoma (Cell Line: TC-71)
|
[2] |
------------------------------------------------------------------------------------ |
|
|
|
|